Register Login

Abiopharma

  • Home
  • About
  • Newsroom
  • Company List
  • Events
  • Automated Tools
  • Contact

News list

PRINSTON INC

  • FDA Approval
  • Aug. 30, 2024, 08:47 UTC
  • 45
  • 0 comments

FDA approve LEVETIRACETAM

Comment Full text

FRESENIUS KABI USA

  • FDA Approval
  • Aug. 30, 2024, 08:47 UTC
  • 60
  • 0 comments

FDA approve OXALIPLATIN

Comment Full text

CHARTWELL RX

  • FDA Approval
  • Aug. 30, 2024, 08:47 UTC
  • 52
  • 0 comments

FDA approve GLYCOPYRROLATE

Comment Full text

HETERO LABS LTD III

  • FDA Approval
  • Aug. 30, 2024, 08:47 UTC
  • 59
  • 0 comments

FDA approve PREGABALIN

Comment Full text

EUGIA PHARMA

  • FDA Approval
  • Aug. 30, 2024, 08:47 UTC
  • 56
  • 0 comments

FDA approve OXALIPLATIN

Comment Full text

WATSON LABS

  • FDA Approval
  • Aug. 30, 2024, 08:47 UTC
  • 57
  • 0 comments

FDA approve RISPERIDONE

Comment Full text

HERITAGE PHARMA

  • FDA Approval
  • Aug. 30, 2024, 08:47 UTC
  • 55
  • 0 comments

FDA approve METOPROLOL TARTRATE

Comment Full text

HETERO LABS LTD III

  • FDA Approval
  • Aug. 30, 2024, 08:47 UTC
  • 42
  • 0 comments

FDA approve DEXTROMETHORPHAN HYDROBROMIDE; QUINIDINE SULFATE

Comment Full text

MYLAN PHARMS INC

  • FDA Approval
  • Aug. 29, 2024, 08:49 UTC
  • 52
  • 0 comments

FDA approve LITHIUM CARBONATE

Comment Full text

EPIC PHARMA LLC

  • FDA Approval
  • Aug. 29, 2024, 08:49 UTC
  • 50
  • 0 comments

FDA approve DOXEPIN HYDROCHLORIDE

Comment Full text
  • Previous
  • 362
  • 363
  • 364
  • 365
  • 366
  • Next

Search

News categories

  • Technical Exchange News(14653)
  • Event(6229)
  • SEC News(390625)
  • FDA Approval(10304)
  • Company Report(721)
  • Business News(237994)
Market reaction

© Copyright Abiopharma. All Rights Reserved
Designed by Alexey Vershinin